FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/05/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
ST13
US500000079404288Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of two adjacent, slightly offset quadrilaterals outlined in blue, displaying the letters "CTGCT" in blue upon a white background, all of which appears above the wording "CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY" in blue.
Titulares
Representantes
Jennifer Fraser Dykema Gossett PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in science; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical materials, namely assays, reagents, and nucleic acids for use in gene and cell therapy research; Chemical preparations for scientific purposes; natural fertilisers; chemical products used in gene and cell therapy technologies, namely viral vectors, plasmids, and lipid nanoparticles for gene delivery; active chemical ingredients used in the manufacture of medicines for diseases and cancer
Classe 5
Pharmaceuticals and medical preparations for the treatment of genetic diseases, neurodevelopmental diseases and cancers; Diagnostic preparations for medical purposes; cells for medical use; pharmaceutical and medical preparations used in gene and cell therapy technologies; pharmaceutical compounds, preparations, and medicines used in the treatment of genetic diseases, neurodevelopmental diseases, and cancers; pharmaceutical compounds, preparations, and medicines used in the treatment of genetic diseases and cancer
Classe 9
Scientific, research, teaching and detecting apparatus and instruments, namely, microscopes, confocal laser microscopes, flow cytometers, bioreactors for cell culturing, cell sorters, and analytical systems composed of microscopes, spectrophotometers, luminometers, spectrofluorimeters, and computer hardware for analyzing cells; downloadable computer software for analyzing biological data, designing gene and cell therapies, and managing laboratory processes in the field of gene and cell therapy; scientific apparatus and instruments, namely, microscopes, confocal laser microscopes, flow cytometers, and bioreactors for cell culturing, and downloadable computer software for analyzing cell populations, designing viral vectors, and optimizing bioreactor processes used in gene and cell therapy technologies; scientific apparatus and instruments, namely, high-throughput confocal microscopes for kinetics measurements and in vivo imaging systems composed of micro CT, magnetic resonance imaging apparatus, not for medical purposes, for live animal imaging in gene and cell therapy research, and downloadable computer software for analyzing genetic sequences and modeling drug responses used in the treatment of diseases and cancer; Prerecorded USB flash drives featuring educational content on gene and cell therapy technologies and their applications in treating diseases and cancer
Classe 10
Surgical and medical apparatus and instruments for use in gene therapy and cell therapy; surgical and medical apparatus and instruments used during medical and surgical procedures; medical apparatuses and instruments, namely, bioreactors, cell sorters, flow cytometers, and analytical systems composed of medical imaging apparatuses all of which provide cell and particle analysis, detection, or counting for medical, medical diagnostic, and therapeutic uses in the field of gene and cell therapy technologies; medical devices used in the treatment of genetic diseases and cancers
Classe 16
Printed matter, namely, printed brochures, reports, and educational materials in the field of gene and cell therapy, advanced therapy medicinal products (ATMPs), and translational medicine; bookbinding tape; printed photographs; stationery and office requisites, namely, printed notepads; printed notebooks; printed journals related to gene and cell therapy technology; printed informational flyers related to the treatment of diseases and cancer
Classe 25
Clothing, namely, lab coats, pants, shirts, t-shirts and headwear
Classe 41
Education, namely, conferences, workshops, seminars, and online courses in the field of gene and cell therapy, advanced therapy medicinal products (ATMPs), and translational medicine and distribution of course material in connection therewith; publication of texts, providing online non-downloadable news articles in the field of gene and cell therapy, ATMPs, and translational medicine, and writing of texts, namely, writing of articles for professional journals other than for advertising or publicity; audio, video, and multimedia production, as well as photography; educational and teaching services, namely, workshops, seminars, conferences, online courses, and hands-on training in the field of gene and cell therapy, ATMPs, and translational medicine; organizing conferences, exhibitions, and competitions in the field of gene and cell therapy, ATMPs, and translational medicine; education, namely, conferences, workshops, seminars, and online courses in the field of gene and cell therapy technology; education, namely, workshops, seminars, and training programs in the treatment of diseases and cancer
Classe 42
Scientific and technological services, namely, research and design in the fields of treatments for genetic diseases, neurodevelopmental diseases and cancers, and gene and cell therapy technology; industrial analysis, industrial research and industrial design services in the fields of treatments for genetic diseases, neurodevelopmental diseases and cancers, and gene and cell therapy technology; quality control and authentication services in the field of gene and cell therapy products; design and development of computer hardware and software; scientific laboratory services; biological and medical research laboratory services; laboratory services, namely, rental of laboratory apparatus and instruments; Research laboratory analysis services in the field of gene therapy, cell therapy, and synthetic biology; biological research, clinical research in the field of gene therapy and cell therapy for genetic diseases, neurodevelopmental diseases and difficult-to-treat cancers, and medical research; design and development of medical technology; development of new technologies for others in the field of gene and cell therapies; design and development of gene and cell therapy technology; scientific research for medical purposes in the field of diseases and cancer
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
28/05/2026
FINAL DISPOSITION NOTICE SENT TO IB
12/05/2026
FINAL DISPOSITION PROCESSED
12/05/2026
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/02/2026
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/02/2026
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/02/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/02/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2025
REGISTERED-PRINCIPAL REGISTER
04/11/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/09/2025
PUBLISHED FOR OPPOSITION
16/09/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
14/08/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/08/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/08/2025
REFUSAL PROCESSED BY IB
19/07/2025
NON-FINAL ACTION WRITTEN
23/06/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
13/05/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/05/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/05/2025
REFUSAL PROCESSED BY IB
21/12/2024
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/12/2024
REFUSAL PROCESSED BY MPU
02/12/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/11/2024
NON-FINAL ACTION WRITTEN
15/11/2024
ASSIGNED TO EXAMINER
14/11/2024
APPLICATION FILING RECEIPT MAILED
16/09/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/09/2024
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/09/2024
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.